Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study
- 11 November 2008
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 20 (5) , 811-817
- https://doi.org/10.1007/s00198-008-0786-9
Abstract
Fracture risk prediction can be enhanced by the concurrent assessment of other clinical risk factors. This study demonstrates that the estimation of an individual’s 10-year probability of fracture by the FRAX® algorithm identifies patients at high risk of fracture who will respond to bisphosphonate therapy.Keywords
This publication has 38 references indexed in Scilit:
- Clodronate Reduces the Incidence of Fractures in Community-Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double-Blind, Placebo-Controlled Randomized StudyJournal of Bone and Mineral Research, 2007
- Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention TrialJournal of Bone and Mineral Research, 2006
- A family history of fracture and fracture risk: a meta-analysisBone, 2004
- A meta-analysis of previous fracture and subsequent fracture riskBone, 2004
- A Meta-Analysis of Prior Corticosteroid Use and Fracture RiskJournal of Bone and Mineral Research, 2004
- Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double-Blind, Placebo-Controlled 3-Year StudyJournal of Bone and Mineral Research, 2004
- Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trialBone, 2003
- Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trialBMJ, 2003
- The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With OsteoporosisJournal of Bone and Mineral Research, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002